[ad_1]
He China National Health Commission Science and Technology Development Center, plans to manufacture 610 million doses of vaccines against covid-19 before the end of the year, and another one billion in 2021.
At a press conference, the director of the center, Zheng Zhongwei, assured that 11 vaccines from five platforms with the participation of the Asian giant are in phase 3 of their clinical trials without showing any adverse results.
“We have had a very strict mechanism to verify any adverse reaction for everyone who has participated in the process. No adverse case was detected”Zhongwei said.
For his part, the director of the biological center of the Ministry of Science and Technology, Zhang Xinmin, made a call for calm in case any vaccine presents adverse effects.
“Some, such as dengue fever, did, but in this case it has not happened. However, more observation time is needed before the phase 3 tests can be concluded, ″ said Xinmin.
Meanwhile, the chief epidemiologist of the China Center for Disease Control and Prevention, Zeng Guang, said the vaccines “look good” and according to preliminary findings “are effective and safe.”
“These vaccines are going to be used in millions of people and the chances of an adverse effect will be higher, so it will be necessary to have a centralized mechanism to monitor its applicationGuang pointed out.
[ad_2]
